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Purpura fulminans due to MSSA Toxic Shock Syndrome
Leah Grant MD and Rachel Plotinsky MD

Introduction

Discussion

Purpura fulminans is a rare and serious complication
of an acute infectious process, characterized by large
purpuric skin lesions, fever, hypotension, and DIC. The
most common infectious cause of purpura fulminans
is meningococcal disease, though few case reports in
the literature describe Staph aureus as a causative
organism.

• In acutely ill patients with skin findings described in
this case as well as multi-organ dysfunction, there are
several life-threatening diagnoses which must be
recognized and treated promptly.
• Given the 50% risk of mortality even with prompt
initiation of therapy for CAPS, we did not delay in
starting this patient on plasma exchange.
• In purpura fulminans, the clotting cascade is disrupted
by bacterial endotoxins and inflammatory cytokines,
leading to a procoagulant and anticoagulant state,
which in turn leads to intravascular thrombosis and
hemorrhagic infarction of the skin.

Case Report
• A 53 year-old woman with a history of heart
block s/p pacemaker placement in 2002 presented to
the ED with nausea, vomiting, fevers, chills, diffuse
muscle pain and a syncopal episode.
• She was found to have multi-organ dysfunction on
labs, including AKI and thrombocytopenia. On hospital
day 2, she developed acrocyanosis. She became febrile
& hypotensive requiring transfer to the ICU for
vasopressor support. Blood cultures were obtained.
She was started on broad-spectrum antibiotic therapy.
• Because of the patient’s thrombocytopenia and overall
critical illness, the differential diagnosis included TTP,
DIC, HUS, drug-induced hemolytic anemia, or a rare
disorder called catastrophic antiphospholipid antibody
syndrome (CAPS).
• She was treated empirically for CAPS with plasma
exchange, heparin, and steroids.
• Blood cultures were positive for methicillin-sensitive
Staph aureus, and antibodies for CAPS were negative.
• Antibiotic therapy was narrowed to Cefazolin, and her
infected pacemaker was extracted.
• She required bilateral below-the-knee amputations as
well as multiple finger amputations due to necrosis.
• Most likely diagnosis is purpura fulminans from MSSA
toxic shock syndrome.
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• A report of 5 cases of purpura fulminans caused by
MSSA TSS was published in the journal Clinical
Infectious Diseases in 2005, and the isolated strains
of MSSA were noted to
produce higher-thanexpected levels of
endotoxins normally
associated with TSS.
• Treatment of purpura
fulminans from MSSA
TSS is antibiotic
therapy.
• It remains a rare and
serious complication
of acute infection
which providers
should keep on their
differential of lifethreatening illnesses
associated with
thrombocytopenia
and purpuric skin
lesions.

